LYB's electricity consumption constitutes approximately 15% of its 2020 baseline scope 1 and 2 greenhouse gas emissions.
Levi Strauss & Co. (LEVI) hinted that a collaboration with superstar Beyonce may be on the horizon in an Instagram post on Monday.
Target's multi-category assortment of owned and exclusive brands and popular national brands makes it a one-stop shopping destination.
XAU/USD remains bullish above $2,632, supported by an upward channel. Key resistance levels at $2,645 and $2,653 could push prices even higher.
On Monday, First Trust revealed their new large cap target outcome ETF, the FT Vest U.S. Equity Equal Weight Buffer ETF – September (RSSE). The fund has a net expense ratio of 0.85%.
Constellation Energy received price target increases Monday after its deal with Microsoft.
MYT Netherlands' strategy, focusing on unique experiences for high-end shoppers, should continue to drive robust growth. MYTE's 4Q24 results show improving margins and strong US market penetration, with US revenue growing 25% y/y. The valuation is attractive, trading at ~7.7x forward EBITDA, with the potential for higher multiples given the improving growth and margin outlook.
Target's fundamentals are improving with positive comparable sales, driven by digital growth and innovative merchandising in categories like Apparel, Home, and Beauty. The Target Circle loyalty program is a key growth driver, enhancing customer insights and enabling personalized offers to boost purchase frequency. Strong operating rigor, prudent inventory management, and a new CFO position Target for margin expansion and continued profitability growth.
My strategy aims for a $50,000 annual income portfolio by age 40, focusing on investments with a 7% yield and 2% annual dividend growth. I prioritize straightforward, defensive businesses with fortress balance sheets, ensuring high dividend coverage and attractive initial yields. This simple, value-oriented approach allows for a buy-and-hold strategy, minimizing the need to worry about short-term fluctuations.
Eli Lilly has surged 58% in 2024, driven by breakthrough weight-loss drugs and strong earnings, with shares now trading above $900. Despite valuation concerns, LLY's high growth rate and reliable earnings make it a buy, supported by strong Q2 results and raised guidance. Key risks include competition and production challenges, but EPS forecasts remain robust, with potential for $30 EPS by 2026.
FedEx stock is plunging Friday after the logistics giant came up short of earnings expectations and revised its full-year outlook. Here's what you need to know.
Target (TGT) is a dependable blue-chip stock with a strong U.S. presence, manageable debt, and a high price/book ratio. Risks include competition, changing consumer preferences, macroeconomic conditions, and maintaining vendor relationships, but Target remains resilient. Target's P/E ratios are below the sector median, indicating potential value despite flat revenue growth. They have solid earnings projections.